文献速递白内障与屈光手术

全身用药与皮质性白内障:新加坡眼病流行病学研究

Systemic medications and cortical cataract: the Singapore Epidemiology of Eye Diseases Study.
PubMed 文献 · Br J Ophthalmol · 2019-07-04

新加坡眼病流行病学研究纳入8965名40岁以上华裔、马来裔和印度裔居民,通过问卷收集用药信息并用改良威斯康星白内障分级系统评估皮质性白内障。调整年龄、性别、族裔、BMI、吸烟、社会经济状况、高血压、高脂血症、糖尿病、糖尿病病程和心血管疾病后,ACE抑制剂、贝特类、α-葡萄糖苷酶抑制剂(AGIs)和胰岛素与皮质性白内障存在显著关联,且与更严重分级一致相关。作者结论指出ACE抑制剂、贝特类和AGIs分别独立于高血压、高脂血症和糖尿病与皮质性白内障患病率升高相关,是否贡献风险需纵向研究确认。

要点

  • ACE抑制剂与皮质性白内障患病相关(OR=1.27;95%CI 1.05-1.55)。
  • 贝特类、AGIs和胰岛素亦与皮质性白内障患病相关。
  • 四种药物同时与皮质性白内障更严重分级一致相关。

核心结论

  • 在该亚洲人群中,ACE抑制剂、贝特类和AGIs分别独立于高血压、高脂血症和糖尿病与皮质性白内障患病率升高相关。
  • 这些药物是否贡献皮质性白内障风险需纵向研究确认。

研究设计与样本

  • 新加坡眼病流行病学研究招募了10033名居住在新加坡的40岁及以上华裔、马来裔和印度裔居民。
  • 用药信息通过问卷访谈收集,皮质性白内障存在与分级采用改良威斯康星白内障分级系统从晶状体照片评估。
  • 药物与皮质性白内障存在的关联采用logistic回归评估,与更严重分级(无、极轻、早期和晚期)的关联采用有序logistic回归评估。
  • 最终纳入8965名参与者,平均年龄57.6岁(SD=9.8),女性4555名(50.8%)。

主要发现

  • 调整年龄、性别、族裔、体重指数、吸烟状态、社会经济状况、高血压、高脂血症、糖尿病、糖尿病病程和心血管疾病后,ACE抑制剂与皮质性白内障存在显著关联(OR=1.27;95%CI 1.05-1.55)。
  • 贝特类与皮质性白内障存在显著关联(OR=1.57;95%CI 1.05-2.35)。
  • α-葡萄糖苷酶抑制剂(AGIs)与皮质性白内障存在显著关联(OR=1.85;95%CI 1.13-3.02)。
  • 胰岛素与皮质性白内障存在显著关联(OR=1.80;95%CI 1.11-2.93)。
  • 进一步调整同时使用的药物并未改变这些关联,且四种药物同样与皮质性白内障更严重分级相关。

临床怎么用

  • 原文未据此给出临床用药推荐。

局限性

  • 原文指出这些药物是否贡献皮质性白内障风险需纵向研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: To evaluate the association between systemic medications and cortical cataract prevalence in an Asian population. METHODS: The Singapore Epidemiology of Eye Diseases Study recruited 10 033 Chinese, Malay and Indian residents aged 40+ years living in Singapore. Information on medication use was collected at interview using questionnaires. The presence and severity of cortical cataract were assessed from lens photographs using the modified Wisconsin Cataract Grading System. Associations between medications and the presence of cortical cataract were assessed using logistic regression. Associations between medications and greater severity of cortical cataract (none, minimal, early and late) were assessed using ordinal logistic regression. RESULTS: A total of 8965 participants were included, the mean age was 57.6 (SD=9.8) years, and 4555 (50.8%) were women. After adjusting for age, gender, ethnicity, body mass index, smoking status, socioeconomic status, hypertension, hyperlipidaemia, diabetes, duration of diabetes and cardiovascular disease, ACE inhibitors (OR=1.27; 95% CI 1.05 to 1.55), fibrates (OR=1.57; 95% CI 1.05 to 2.35), alpha-glucosidase inhibitors (AGIs) (OR=1.85; 95% CI 1.13 to 3.02) and insulin (OR=1.80; 95% CI 1.11 to 2.93) were significantly associated with the presence of cortical cataract. Further adjusting for concurrent medication use did not alter these associations. Consistently, the four medications were also associated with a greater severity level of cortical cataract. CONCLUSION: ACE inhibitors, fibrates and AGIs were associated with increased prevalence of cortical cataract in this Asian population, independent of the presence of hypertension, hyperlipidaemia and diabetes, respectively. Whether they contribute to the risk of cortical cataract needs confirmation in longitudinal studies.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Dai W, Tham YC, Chee ML, et al. Systemic medications and cortical cataract: the Singapore Epidemiology of Eye Diseases Study. Br J Ophthalmol. 2019. PMID: 31272959. doi:10.1136/bjophthalmol-2019-314256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。